Kamagra Oral Jelly 100 mg (Sildenafil Citrate) - 7 Sachets

Product Description

Kamagra Oral Jelly Vol I is a pharmaceutical product listed by the supplier as containing sildenafil citrate in an oral jelly formulation. The supplied product information identifies the strength as 100 mg and describes a retail pack containing seven individual sachets. Each sachet is listed as containing 5 g of jelly. The product is associated with the sildenafil category of medicines used in the management of erectile dysfunction, subject to applicable regulatory authorization and medical supervision. Composition and Formulation According to the supplied catalogue, the active ingredient is sildenafil citrate, with a stated strength of 100 mg per 5 g sachet. The dosage form is described as an oral jelly, and the packaging consists of individual sachets supplied together in a box. The complete ingredient list, including inactive ingredients, is not available in the supplied information and should be confirmed through authentic product documentation. Sildenafil belongs to a class of medicines known as phosphodiesterase type 5 (PDE5) inhibitors. Its pharmacological action involves the nitric oxide and cyclic guanosine monophosphate pathway, which contributes to smooth muscle relaxation and blood flow in penile tissue during sexual stimulation. This general pharmacological information does not establish the quality, safety, effectiveness or regulatory status of any specific product sold under the Kamagra name. Packaging and Available Flavours The supplier lists Kamagra Oral Jelly Vol I in a box containing seven sachets, each with a stated net content of 5 g. The total listed jelly content per box is 35 g. The catalogue identifies seven flavour options: pineapple, orange, strawberry, vanilla, banana, black currant and butterscotch. The supplied description refers to an assortment of flavours within the pack. However, the exact flavour allocation, individual sachet labelling and availability of each variant should be confirmed before a product listing is published. Buyers should rely on the actual packaging and verified product documentation rather than assuming every pack contains a particular flavour combination. Product Information for Procurement Teams The supplier identifies the brand as Kamagra and the variant as Kamagra Oral Jelly Vol I. Ajanta Pharma is named as the manufacturer in the supplied information, while India is stated as the country of origin. These details require independent verification against the manufacturer's documentation and the physical product packaging. The catalogue also states a shelf life of 36 months and describes a bulk carton containing 300 retail packs, with a listed carton weight of 18.5 kg. These values should be checked against the relevant batch documentation, carton labelling and current supplier records before they are used for inventory planning or commercial procurement. Safety and Regulatory Verification Sildenafil can interact with nitrate-containing medicines and certain other drugs, potentially causing a dangerous fall in blood pressure. Use of sildenafil requires appropriate medical assessment, and patients should follow the instructions of a qualified healthcare professional. Sudden vision or hearing changes, chest pain or an erection lasting more than four hours require urgent medical attention. Before purchase, distribution or publication, verify the product's authorization in the intended market, manufacturer identity, batch number, expiry date, storage instructions and authenticity. The product-specific claims and regulatory status in the supplier listing have not been independently established. Do not treat advertised flavour options, packaging details or supplier statements as evidence of regulatory approval or clinical performance.

Additional Product Details

No additional product details available.

Product Specifications

Business Information